Works cited by this work

70 works

Work: SLAMF1 at the crossroads of immunity and disease: Biology, pathology, and therapeutic opportunities

1. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy

   Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi +3

   Review article20233 citations

   ABIABI:AkademIndex/openalex/2026.other.458827

2. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2

   Lisa von Wenserski, Christoph Schultheiß, Sarah Naomi Bolz +10

   Article20202 citations

   ABIABI:AkademIndex/openalex/2026.other.431187

3. SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus

   Morgane Humbel, Florence Bellanger, Alice Horisberger +8

   Article20222 citations

   ABIABI:AkademIndex/openalex/2026.other.431197

4. SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors

   Jaime De Calisto, Ninghai Wang, Guoxing Wang +3

   Article20142 citations

   ABIABI:AkademIndex/openalex/2026.other.458798

5. SLAM family receptors in natural killer cells – Mediators of adhesion, activation and inhibition via cis and trans interactions

   Maren Claus, Doris Urlaub, Frank Fasbender +1

   Review article20182 citations

   ABIABI:AkademIndex/openalex/2026.other.458806

6. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma

   Na Song, Ziwei Wang, Pingyu Shi +7

   Article20242 citations

   ABIABI:AkademIndex/openalex/2026.other.458839

7. Homotypic Interactions Mediated by Slamf1 and Slamf6 Receptors Control NKT Cell Lineage Development

   Klaus Griewank, Christine Borowski, Svend T. Rietdijk +6

   Article20072 citations

   ABIABI:AkademIndex/openalex/2026.other.778842

8. Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors

   Ninghai Wang, Peter J. Halibozek, Burcu Yigit +5

   Article20152 citations

   ABIABI:AkademIndex/openalex/2026.other.778845

9. Identification of CD84 as a potent survival factor in acute myeloid leukemia

   Ying‐Hui Zhu, Mariam Murtadha, Miaomiao Liu +25

   Article20252 citations

   ABIABI:AkademIndex/openalex/2026.other.778901

10. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853195

11. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853196

12. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853197

13. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853198

14. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853199

15. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853200

16. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853201

17. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853202

18. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853203

19. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853204

20. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853205

21. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853206

22. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853207

23. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853208

24. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853209

25. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.853210